Across TCGA pan-cancer cohorts, OR5B10P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR5B10P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR5B10P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR5B10P is over-expressed in tumor.
KIRC are the cancer types where OR5B10P tumor–normal differential expression is most reproducible.